Alpha Profiles · Company Profile

OCULAR THERAPEUTIX, INC

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/ocular-therapeutix-inc

Entity: Public listing published
Primary listing: NASDAQ: OCUL
Verification: Partially verified
Last reviewed: 2026-09-13T04:45:53.225961+00:00

Overview

Alpha's canonical identity and public leadership record for OCULAR THERAPEUTIX, INC.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

10 public records

David Robinson

Global Chief Commercial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-053176Apr 30, 2026

Donald Notman

Chief Operating Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-053176Apr 30, 2026

Jason Robins

Interim Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-053176Apr 30, 2026

Jeffrey Heier, M.D.

Chief Scientific Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-053176Apr 30, 2026

Nadia Waheed, M.D.

Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-053176Apr 30, 2026

Namrata Saroj, OD

Chief Business Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-053176Apr 30, 2026

Peter K. Kaiser, M.D.

Chief Development Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-053176Apr 30, 2026

Pravin U. Dugel, M.D.

Executive Chairman, President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-053176Apr 30, 2026

Sanjay Nayak, M.B.B.S., Ph.D.

Chief Strategy Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-053176Apr 30, 2026

Todd D.C. Anderman

Chief Legal Officer and Secretary

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001104659-26-053176Apr 30, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 13, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.